The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.

MLA

Talia, Marianna, et al. “The G Protein Estrogen Receptor (GPER) Is Involved in the Resistance to the CDK4/6 Inhibitor Palbociclib in Breast Cancer.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, June 2024, pp. 1–22. EBSCOhost, https://doi.org/10.1186/s13046-024-03096-7.

APA

Talia, M., Cirillo, F., Scordamaglia, D., Di Dio, M., Zicarelli, A., De Rosis, S., Miglietta, A. M., Capalbo, C., De Francesco, E. M., Belfiore, A., Grande, F., Rizzuti, B., Occhiuzzi, M. A., Fortino, G., Guzzo, A., Greco, G., Maggiolini, M., & Lappano, R. (2024). The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1–22. https://doi.org/10.1186/s13046-024-03096-7

Chicago

Talia, Marianna, Francesca Cirillo, Domenica Scordamaglia, Marika Di Dio, Azzurra Zicarelli, Salvatore De Rosis, Anna Maria Miglietta, et al. 2024. “The G Protein Estrogen Receptor (GPER) Is Involved in the Resistance to the CDK4/6 Inhibitor Palbociclib in Breast Cancer.” Journal of Experimental & Clinical Cancer Research (17569966) 43 (1): 1–22. doi:10.1186/s13046-024-03096-7.